4.8 Review

The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer

期刊

FRONTIERS IN IMMUNOLOGY
卷 11, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.00604

关键词

exosomal PD-L1; biogenesis; immunosuppression; T cells; biomarker; immunotherapy

资金

  1. National Natural Science Foundation of China [81972636, 81872281, 81472595]
  2. Natural Science Foundation of Hunan Province [2019JJ40175, 2019JJ40183, 2018JJ3634, 2018JJ1013]
  3. Research Projects of Health Commission of Hunan Province [20201772, B20180400, B20180582]
  4. Research Projects of Health Department of Hunan Province [B2013-096]
  5. Changsha Science and Technology Project [kq1901071, kq1901072, kq1706045, kq1706043]
  6. Ascend Foundation of National cancer center [NCC2018b68]
  7. Humanities and Social Science Youth Fund of Ministry of Education of China [19YJCZH254]

向作者/读者索取更多资源

The exosome serves as a trafficking vehicle for transport of programmed death-ligand 1 (PD-L1) into receptor cells. In tumor microenvironment, distant tumor cells can remotely attack activated T cells by exosomal PD-L1. Here, we summerize the biogenesis and transport process of exosomal PD-L1. Then, we focus on the cancer biology of exosomal PD-L1 in immunosuppression and the mechanism by which it inhibits T cells. Finally, we highlight the prospects of exosomal PD-L1 as a tumor biomarker and its significance in immunotherapy. In addition, we discuss the new challenges faced in researching and utilizing exosomal PD-L1. This review may shed light on the exosomal PD-L1 from the bench to the clinic. Exosomes serve as trafficking vehicles for transport of programmed death-ligand 1 (PD-L1) into receptor cells. In tumor microenvironment, distant tumor cells can remotely attack activated T cells through exosomal PD-L1. Here, we have summarized the biogenesis and transport of exosomal PD-L1. Next, we focused on the cancer biology of exosomal PD-L1 in immunosuppression and the mechanism by which it inhibits T cells. Finally, we highlighted the prospects of exosomal PD-L1 as a tumor biomarker and its significance in immunotherapy. In addition, we have discussed the new challenges faced in studying and utilizing exosomal PD-L1. This review may shed light on the translation of exosomal PD-L1 from bench to clinic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据